— Know what they know.
Not Investment Advice

MEIP NASDAQ

MEI Pharma, Inc.
1W: +2.4% 1M: -38.5% 3M: +0.0% 1Y: -5.5% 3Y: -58.1% 5Y: -94.7%
$3.07
Last traded 2025-10-06 — delisted
NASDAQ · Healthcare · Biotechnology · $20.5M mcap · 6M float · 26.83% daily turnover · Short 50% of daily vol

Supply Chain Overview

2 relationships
0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2024-10-25
Earliest Filing
2025-09-04
Latest Filing

Mentioned As Counterparty

2 mentions

Other companies that named MEIP in their SEC 8-K filings.

Filed By Relationship Summary Filing Date SEC
LITS MEI Pharma, Inc. supplier Borrower seeking loans of Digital Currency or USD from Lender 2025-09-04 View
LITS MEI Pharma, Inc. acquirer Sold assets related to ME-344 to Aardvark Therapeutics, Inc. 2024-10-25 View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms